Načítá se...

Bromodomain inhibitors a decade later: a promise unfulfilled?

Over the last decade, bromodomain inhibitors have emerged as a promising class of anticancer drugs. However, the clinical progress of these agents has faced significant obstacles, which precluded their regulatory approval. This editorial will review the challenges and opportunities associated with t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Mita, Monica M., Mita, Alain C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7722711/
https://ncbi.nlm.nih.gov/pubmed/32989227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01079-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!